Blood Sugar Beliefs.

SugarAndSpike “Glucagon, cortisol, adrenalin, growth hormone and thyroid tend to increase the blood sugar, but it is common to interpret hyperglycemia as “diabetes,” without measuring any of these factors.”Ray Peat PhD

It’s perfectly understandable for it to appear as self-evident, that sugar restriction will result in the lowering of blood sugar levels, and that this – so called improvement in the symptoms of what is often referred to as diabetes – is representative of some kind of metabolic recovery.

Unfortunately this is a potentially very misleading idea, which – when looked at from a more appropriate physiological perspective – no longer seems logical, nor does it appear to be supported by much in the way of high quality experimental evidence.

“Dietary intakes of total carbohydrates, starch, sucrose, lactose or maltose were not significantly related to diabetes risk after adjustment for confounders…fructose was inversely related to diabetes risk.. The replacement of 5 % energy intake from SFA [saturated fat] with…fructose was associated with a 30 % lower diabetes risk…” (Ahmadi-Abhari S, et al., 2014)

Although there are many things which increase blood sugar (and not all of them are harmful), chronic hyperglycemia – often a symptom of metabolic dysfunction – has been shown to be alleviated by the introduction of greater amounts of sucrose or fruit sugar in the diet, rather than by its avoidance.

“Fasting plasma glucose levels fell in all subjects and oral glucose tolerance…significantly improved after 10 days of high carbohydrate feeding. Fasting insulin levels also were lower on the high carbohydrate diet…” (John D. Brunzell, et al., 1971)

Before you get carried away, I’m not saying the only thing wrong, when someone has problems properly regulating blood sugar, is that they aren’t eating enough sugar.

However, talking about sugar dysregulation issues in a simplistic sugar-blaming manner, without looking at the impact that biological stress can have on proper metabolic function, is at the very least, unhelpful and misleading. And the assumption that high blood sugar or hyperglycemia is necessarily driving the diabetic state and associated metabolic damage, is also likely inaccurate.

“Compared with [YesBreakfast]…plasma glucose, FFA [free fatty acids], and glucagon were 36.8, 41.1, and 14.8% higher, respectively… on the [NoBreakfast] day…Skipping breakfast increases PPHG [postprandial hyperglycemia] after lunch and dinner in association with…impaired insulin response.” (Jakubowicz D, et al., 2015)

“Recent clinical studies…found that T2D patients treated to maintain glycemia below the diabetes definition threshold…still develop diabetic complications. This suggests additional insulin- and glucose-independent mechanisms could be involved in T2D progression and/or initiation…” (Moraru A, et al., 2018)

“…mortality risk did not increase with hyperglycemia unless associated with simultaneous hyperlactatemia…intensive insulin therapy may not be the most plausible approach to curtailing mortality risk….further efforts might be focused on understanding and regulating lactate metabolism as the key energy mediator and mortality risk predictor…” (Green JP, Berger T, et al., 2012)

When decisions regarding health are made on the basis of the idea that consuming too much sugar causes ‘diabetes’, it makes sense to me that the long term results would quite often be far from good. I’m not a doctor, and none of this is intended as health advice, but as far as I have been able to tell, there is little in the way of evidence, showing that sugar consumption is what is really to blame.

When sugar is restricted, and (after a little while) when glycogen stores are depleted, both cortisol and adrenalin rise in an attempt to maintain the supply of blood sugar, as well as making available an alternative fuel in the form of free fatty acids released from storage.

Cortisol maintains blood sugar – partly by blocking the use of sugar for many purposes (eg. immune cell function) and – by converting valuable muscle and other tissue into fuel for cells.

At the same time, when fats released from storage are polyunsaturated (PUFAs), they can lead to a chronic inability of cells to use glucose, further promoting hyperglycemia, and the release of more cortisol.

The by-products of oxidation of PUFAs are now known to directly stimulate cortisol synthesis.

The breakdown products of PUFAs have been found to be closely associated with the progression and severity of symptoms of type 2 diabetes.

“Diabetic population as a whole showed higher MDA [malondialdehyde] plasma levels compared to controls…The patients with a poor metabolic control showed the highest plasma MDA concentrations…” (Noberasco G, et al., 1991)

“…our study suggests that hyperglycemia in newly diagnosed patients with Type 2 DM is associated with elevated OS [oxidative stress] through increased lipid peroxidation…” (Manohar SM, et al., 2013)

“In diabetic patients a positive correlation was found between plasma MDA levels and mean daily blood glucose…results confirm the increase of lipid peroxidation during Type 2 diabetes. The correlation with the degree of metabolic imbalance suggests a possible role for lipid peroxidation in the occurrence of glucose-induced macromolecular changes.” (Altomare E, et al., 1992)

“In both groups of type 2 D.M, serum MDA levels were significantly higher than the normal. In type 2 DM with myocardial infarction, MDA levels were significantly higher than Type 2 cases without any complications.” (Mahreen R, et al., 2010)

Adrenalin and cortisol (as well as PUFAs) can cause insulin resistance, and this – in combination with the above and other factors – encourages blood sugar dysregulation and other related degenerative and diabetogenic symptoms.

Even though it is the starches (or complex carbohydrates) which are generally recommended – often to those with chronically high blood sugar – as a ‘healthy’ alternative to sucrose or fruit sugar, they can raise blood sugar more rapidly and to a greater degree, largely because of the way in which they quickly convert to pure glucose.

As a result of this more insulin needs to be secreted, a factor which can be responsible for the exacerbation of many issues associated with high blood sugar or ‘diabetes’. The blood sugar lowering or hypoglycemic effects of raised insulin, can promote the excessive release of cortisol and adrenalin, and an increase in circulating levels of PUFAs, causing hyperglycemia as well as increased fat production and eventually obesity.

The stress promoting effects of chronically raised insulin are a significant cause of metabolic illness and the degenerative symptoms that go along with the so called diabetic state.

Contrary to popular opinion, the fructose component of fruit sugar or sucrose, not only slows the rate at which glucose enters the blood stream, but also significantly reduces the insulinagenic effects of glucose, improving or preventing many of the above reactions.

Fructose by itself, does not require insulin for it to be metabolized, and as such has been shown to effectively promote the replenishment of glycogen stores, protecting against the stress effects that often lead to the diagnosis of diabetes.

“…low dose fructose improves the glycemic response to an oral glucose load in normal adults without significantly enhancing the insulin or triglyceride response. Fructose appears most effective in those normal individuals who have the poorest glucose tolerance.” (Moore MC, et al. 2000)

“…analyses of short-term controlled feeding trials showed that isocaloric fructose replacement of other carbohydrates resulted in clinically significant improvements in glycemic controlwithout significantly affecting insulin in diabetic individuals.” (Cozma AI, et al., 2012)

It’s possible that replacing sugar with starch or ‘complex carbohydrates’ might initially provide the illusion of improvement with regards to hyperglycaemia, by increasing exposure to insulin, and temporarily giving the impression that lower blood sugar readings are the result of disease remission and an overall improvement in health.

It is long term consumption of PUFAs, that is one of the most potent promoters of stress and systemic inflammation, creating the conditions that are so often wrongly blamed on too much white sugar in the diet.

Under circumstances such as these, chronic and excessive exposure to stress of many different kinds, particularly when sugar is restricted – or in combination with over consumption of the starchy glucose producing carbohydrates – can promote the factors (insulin resistance, high cortisol and adrenalin, and rising levels of polyunsaturated free fatty acids) which worsen blood sugar regulation capability.

Confusion can arise as a result of the ability of cortisol (and other stress substances) – at least in the short term – to suppress symptoms and provide a certain amount of improvement in the way a person feels.

Removing all forms of sugar (including starches) from the diet, can sometimes create the illusion of an improvement in blood sugar regulation issues, by temporarily lowering readings, giving a false impression of health improvement by suppressing a number of metabolic requirements.

High protein intake – in the absence of enough sugar – can also reduce blood glucose levels when insulin (which is secreted as a necessary part of protein absorption and synthesis) removes sugar from the blood. This kind of diet over a period of time, can advance diabetes related problems, whilst also being able to appear at first like a metabolic improvement.

The potentially hypoglycemic effects of this scenario, when stress and exposure to PUFAs is already an issue, can set in motion a vicious circle of low and high blood sugar, and associated problems.

A high fat low sugar diet – particularly when high in PUFAs – interferes with thyroid energy systems, slowing liver function. A sluggish, under active liver, is a cause of low blood sugar and stress, and even though it is becoming more and more common for indicators of stress to be seen as if they were a sign of the effectiveness of a dietary approach, the long term results are often faster aging, chronic inflammatory illness, and degeneration.

The avoidance of starchy carbohydrates can sometimes be helpful as a means to reducing metabolic dysfunction (including improvement in blood sugar regulation), partly because of a reduction in exposure to bacterial endotoxin. But it’s important to ensure there is still sufficient energy available to fuel thyroid metabolism, digestion, and detoxification. Sucrose and fructose are great candidates for this position.

Insufficient sugar suppresses thyroid function, inhibiting digestion and intestinal barrier function, increasing exposure to endotoxin, and endotoxin (LPS) can cause inflammation, hyperglycemia, and insulin resistance.

“Lipopolysaccharides (LPS) of the cell wall of gram-negative bacteria trigger inflammation, which is associated with marked changes in glucose metabolism. Hyperglycemia is frequently observed during bacterial infection and it is a marker of a poor clinical outcome in critically ill patients.” (Nguyen AT, et al., 2014)

“…data suggest that metabolic endotoxemia could be involved in the pathogenesis of insulin resistance in obese and T2DM subjects…” (Liang H, et al., 2013)

Suppression of thyroid energy systems, and increased endotoxin circulation, can also lead to a rise in other substances of stress, like estrogen, serotonin, nitric oxide, and lactate, and these substances are associated with high blood sugar, and other diabetes related issues. Dealing with stress, and improving thyroid/oxidative metabolism, moves functioning away from overreliance on the stress systems.

“The data suggest that estrogen…may relate to deterioration of glucose tolerance. Longer duration of estrogen use among current users may relate to an increased risk of type 2 diabetes.” (Zhang Y, et al., 2002)

“The enterochromaffin cells of the gastrointestinal tract produce peripheral serotonin postprandially….it induces a decrease in the concentration of circulating lipids as well as hyperglycemia and hyperinsulinemia…” (Watanabe H, et al., 2011)

“…it was established that NIDDM…patients have significantly greater plasma 5-HT concentrations…” (Barradas MA, et al., 1988)

“Increased expression of iNOS induced hepatic insulin resistance and hyperglycemia at least in part by impairing insulin signaling at multiple levels…” (Shohei Shinozaki, et al., 2011)

“In line with experimental evidence, we could demonstrate in humans that poor glycemic control is related to higher NO activity and hyperperfusion of the kidney.” (Schneider MP, et al., 2013)

To put it another way, sugar is a basic anti-stress pro-thyroid substance, and a fundamental factor protecting against rising levels of stress. Sugar plays a crucial role in the production of the anti-stress cholesterol, and the subsequent conversion of cholesterol into the anti-inflammatory protective hormones, such as pregnenolone, progesterone and testosterone, also shown to protect against symptoms associated with diabetes.

Even though the idea of removing white ‘processed’ sugar from the diet has been made to sound appealing, as a very simple solution to chronic hyperglycemia or blood sugar dysregulation issues (and related metabolic problems), there are a number of biologically logical reasons to avoid that trap.

The relationship between increased lactate production, diabetes, and cancer progression, is one example of what can be at stake, if the oxidative metabolism interfering (carbon dioxide lowering) impact of too much exposure to PUFAs and other substances of stress, are set aside, in favor of a sugar demonizing ideology. This can be shocking, once you become aware of the impact that excessive restriction of sugar can have in relation to stress, inflammation, and disease.

“…data indicate that chronical hyperlactatemia might indicate the early stages of insulin resistance and contributes to the onset of diabetes…A common feature of primary and metastatic cancers is increase in glycolysis rate, leading to augmented glucose uptake and lactate formation, even under normal oxygen conditions.” (Wu Y, et al., 2016)

A far more rational method seems to call for avoiding PUFAs, in the context of a diet that aims to promote thyroid metabolism and lower cortisol, adrenalin, as well as free fatty acid release, by providing sufficient protein and other nutrients (from milk, cheese, or gelatin) and plenty of simple sugars, from sweet ripe juicy fruits, fruit juice, honey, and white sugar.

Some other things that have been shown to improve blood sugar regulation, include aspirin, biotin, thiamine, glycine, minocycline, coffee and caffeine, taurine, famotidine, niacinamide, cyproheptadine, methylene blue, activated charcoal, and a number of other stress and inflammation lowering things.

Have you experienced the long term effects of the removal of PUFAs, on the ability to effectively and efficiently metabolize sugar?

See more here

Diabetes Care. 2001 Nov;24(11):1882-7. Acute fructose administration improves oral glucose tolerance in adults with type 2 diabetes. Moore MC, Davis SN, Mann SL, Cherrington AD.

Anaesthesist. 1995 Nov;44(11):770-81. Fructose vs. glucose in total parenteral nutrition in critically ill patients. Adolph M, Eckart A, Eckart J.

J Clin Endocrinol Metab. 2012 Jul;97(7):E1182-6. Skeletal muscle lipid peroxidation and insulin resistance in humans. Ingram KH, Hill H, Moellering DR, Hill BG, Lara-Castro C, Newcomer B, Brandon LJ, Ingalls CP, Penumetcha M, Rupp JC, Garvey WT.

Diabetes Metab. 2005 Apr;31(2):178-88. Consumption of carbohydrate solutions enhances energy intake without increased body weight and impaired insulin action in rat skeletal muscles. Ruzzin J, Lai YC, Jensen J.

Exp Clin Psychopharmacol. 2010 Feb;18(1):78-86. Effects of acute progesterone administration upon responses to acute psychosocial stress in men. Childs E, Van Dam NT, de Wit H.

Am J Clin Nutr. 1993 Nov;58(5 Suppl):766S-770S. Fructose and dietary thermogenesis. Tappy L, Jéquier E.

J Clin Invest. 2001 Aug;108(3):437-46. Prevention of fat-induced insulin resistance by salicylate. Kim JK, Kim YJ, Fillmore JJ, Chen Y, Moore I, Lee J, Yuan M, Li ZW, Karin M, Perret P, Shoelson SE, Shulman GI.

J Clin Endocrinol Metab. 2000 Dec;85(12):4515-9. Acute fructose administration decreases the glycemic response to an oral glucose tolerance test in normal adults. Moore MC, Cherrington AD, Mann SL, Davis SN.

Thyroid. 2008 Feb;18(2):227-37. Links between thyroid hormone action, oxidative metabolism, and diabetes risk? Crunkhorn S, Patti ME.

Life Sci. 1988;42(13):1323-30. Biotin supplementation improves glucose and insulin tolerances in genetically diabetic KK mice. Reddi A, DeAngelis B, Frank O, Lasker N, Baker H.

Diabetes Care. 2012 Jul;35(7):1611-20. Effect of fructose on glycemic control in diabetes: a systematic review and meta-analysis of controlled feeding trials. Cozma AI, Sievenpiper JL, de Souza RJ, Chiavaroli L, Ha V, Wang DD, Mirrahimi A, Yu ME, Carleton AJ, Di Buono M, Jenkins AL, Leiter LA, Wolever TM, Beyene J, Kendall CW, Jenkins DJ.

PLoS One. 2012;7(6):e38734. Activation of Pregnane X Receptor by Pregnenolone 16 α-carbonitrile Prevents High-Fat Diet-Induced Obesity in AKR/J Mice. Ma Y, Liu D.

Br J Nutr. 2014 Jan 28;111(2):342-52. Dietary intake of carbohydrates and risk of type 2 diabetes: the European Prospective Investigation into Cancer-Norfolk study. Ahmadi-Abhari S, Luben RN, Powell N, Bhaniani A, Chowdhury R, Wareham NJ, Forouhi NG, Khaw KT.

Comp Biochem Physiol C Toxicol Pharmacol. 2003 Apr;134(4):521-7. Effect of glycine in streptozotocin-induced diabetic rats. Alvarado-Vásquez N, Zamudio P, Cerón E, Vanda B, Zenteno E, Carvajal-Sandoval G.

Cell Metab. 2018 Mar 6;27(3):549-558.e4. Paracrine Interactions within the Pancreatic Islet Determine the Glycemic Set Point. Rodriguez-Diaz R, Molano RD, Weitz JR, Abdulreda MH, Berman DM, Leibiger B, Leibiger IB, Kenyon NS, Ricordi C, Pileggi A, Caicedo A, Berggren PO.

Mediators Inflamm. 2016;2016:6456018. Lactate, a Neglected Factor for Diabetes and Cancer Interaction. Wu Y, Dong Y, Atefi M, Liu Y, Elshimali Y, Vadgama JV.

Eur J Nutr. 2013 Oct;52(7):1821-4. High-dose thiamine supplementation improves glucose tolerance in hyperglycemic individuals: a randomized, double-blind cross-over trial. Alaei Shahmiri F, Soares MJ, Zhao Y, Sherriff J.

Neuroscience. 2017 May 14;350:1-12. Progesterone modulates diabetes/hyperglycemia-induced changes in the central nervous system and sciatic nerve. Atif F, Prunty MC, Turan N, Stein DG, Yousuf S.

Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3096-9. High fat diet-induced hyperglycemia: prevention by low level expression of a glucose transporter (GLUT4) minigene in transgenic mice. Ikemoto S, Thompson KS, Takahashi M, Itakura H, Lane MD, Ezaki O.

Diabetes. 1995 Jun;44(6):718-20. Amelioration of high-fat feeding-induced insulin resistance in skeletal muscle with the antiglucocorticoid RU486. Kusunoki M, Cooney GJ, Hara T, Storlien LH.

Int J Inflamm Cancer Integr Ther 2016, 3:136. Minocycline Attenuates Severe Hyperglycemia in Patient with Lipodystrophy. Douglas Y, Grant MB, Moshiree B.

Acad Emerg Med. 2012 Nov;19(11):1268-75. Hyperlactatemia Affects the Association of Hyperglycemia with Mortality in Nondiabetic Adults With Sepsis. Green JP, Berger T, Garg N, Horeczko T, Suarez A, Radeos MS, Hagar Y, Panacek EA.

N Engl J Med. 1971 Mar 11;284(10):521-4. Improved Glucose Tolerance with High Carbohydrate Feeding in Mild Diabetes. Brunzell JD, Lerner RL, Hazzard WR, Porte D Jr, Bierman EL.

J Clin Invest. 2018 May 1;128(5):1888-1902. Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes. Ostrov DA, Alkanani A, McDaniel KA, Case S, Baschal EE, Pyle L, Ellis S, Pöllinger B, Seidl KJ, Shah VN, Garg SK, Atkinson MA, Gottlieb PA, Michels AW.

Exp Mol Med. 2012 Nov 30;44(11):665-73. Taurine ameliorates hyperglycemia and dyslipidemia by reducing insulin resistance and leptin level in Otsuka Long-Evans Tokushima fatty (OLETF) rats with long-term diabetes. Kim KS, Oh DH, Kim JY, Lee BG, You JS, Chang KJ, Chung HJ, Yoo MC, Yang HI, Kang JH, Hwang YC, Ahn KJ, Chung HY, Jeong IK.

Minerva Med. 2013 Feb;104(1):93-101. Plasma AGE-peptides and C-peptide in early-stage diabetic nephropathy patients on thiamine and pyridoxine therapy. Cetin E, Civelek S, Andican G, Candan Polizzi F, Yumuk V, Burçak G.

Ann Nutr Metab. 2006;50(2):115-20. Relationship between insulin resistance and lipid peroxidation and antioxidant vitamins in hypercholesterolemic patients. Shin MJ, Park E, Lee JH, Chung N.

Nature. 2018 Mar 29;555(7698):673-677. Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance. Ghorpade DS, Ozcan L, Zheng Z, Nicoloro SM, Shen Y, Chen E, Blüher M, Czech MP, Tabas I.

Cell Metab. 2018 Apr 3;27(4):926-934.e8. Elevated Levels of the Reactive Metabolite Methylglyoxal Recapitulate Progression of Type 2 Diabetes. Moraru A, Wiederstein J, Pfaff D, Fleming T, Miller AK, Nawroth P, Teleman AA.

J Diabetes Sci Technol. 2015 Oct 14;9(6):1192-9. Fluctuations of Hyperglycemia and Insulin Sensitivity Are Linked to Menstrual Cycle Phases in Women With T1D. Brown SA, Jiang B, McElwee-Malloy M, Wakeman C, Breton MD. 

Diabetes Care. 2015 Oct;38(10):1820-6. Fasting until noon triggers increased postprandial hyperglycemia and impaired insulin response after lunch and dinner in individuals with type 2 diabetes: a randomized clinical trial. Jakubowicz D, Wainstein J, Ahren B, Landau Z, Bar-Dayan Y, Froy O.

Nutr Diabetes. 2014 Jun 30;4:e123. Effect of chronic coffee consumption on weight gain and glycaemia in a mouse model of obesity and type 2 diabetes. Rustenbeck I, Lier-Glaubitz V, Willenborg M, Eggert F, Engelhardt U, Jörns A.

Diabetes. 2014 Feb;63(2):471-82. Lipopolysaccharides-mediated increase in glucose-stimulated insulin secretion: involvement of the GLP-1 pathway. Nguyen AT, Mandard S, Dray C, Deckert V, Valet P, Besnard P, Drucker DJ, Lagrost L, Grober J.

Am J Physiol Regul Integr Comp Physiol. 2003 Jun;284(6):R1631-5. An oxidized metabolite of linoleic acid stimulates corticosterone production by rat adrenal cells. Bruder ED, Ball DL, Goodfriend TL, Raff H.

Br J Nutr. 2012 Jan;107(1):86-95. Chronic caffeine intake decreases circulating catecholamines and prevents diet-induced insulin resistance and hypertension in rats. Conde SV, Nunes da Silva T, Gonzalez C, Mota Carmo M, Monteiro EC, Guarino MP.

Cell. 2016 Feb 25;164(5):872-83. UCP2 regulates mitochondrial fission and ventromedial nucleus control of glucose responsiveness. Toda C, Kim JD, Impellizzeri D, Cuzzocrea S, Liu ZW, Diano S.

J Endocrinol Invest. 2008 Aug;31(8):694-9. Glycine treatment decreases proinflammatory cytokines and increases interferon-gamma in patients with type 2 diabetes. Cruz M, Maldonado-Bernal C, Mondragón-Gonzalez R, Sanchez-Barrera R, Wacher NH, Carvajal-Sandoval G, Kumate J.

Endocr Res. 2002 Nov;28(4):325-30. Oxidized products of linoleic acid stimulate adrenal steroidogenesis. Goodfriend TL, Ball DL, Raff H, Bruder ED, Gardner HW, Spiteller G.

Eur J Nutr. 2013 Oct;52(7):1821-4. High-dose thiamine supplementation improves glucose tolerance in hyperglycemic individuals: a randomized, double-blind cross-over trial. Alaei Shahmiri F, Soares MJ, Zhao Y, Sherriff J.

Tohoku J Exp Med. 2004 Jul;203(3):211-8. Lipid peroxidation and resistance to oxidation in patients with type 2 diabetes mellitus. Pasaoglu H, Sancak B, Bukan N.

PLoS One. 2013 May 21;8(5):e63983. Effect of Lipopolysaccharide on Inflammation and Insulin Action in Human Muscle. Liang H, Hussey SE, Sanchez-Avila A, Tantiwong P, Musi N.

Diabetes Metab Res Rev. 1999 Nov-Dec;15(6):427-41. Review. Neuroendocrine perturbations as a cause of insulin resistance. Björntorp P.

Journal of Endocrinology, Metabolism and Diabetes of South Africa, 22:2, 21-25, 2016. Decreased total antioxidant levels and increased oxidative stress in South African type 2 diabetes mellitus patients. FA Ganjifrockwala, JT Joseph & G George.

J Med Assoc Thai. 2010 Jun;93(6):682-93. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients. Likidlilid A, Patchanans N, Peerapatdit T, Sriratanasathavorn C.

Metabolic Endotoxemia Initiates Obesity and Insulin Resistance. Patrice D. Cani, Jacques Amar, Miguel Angel Iglesias, Marjorie Poggi, Claude Knauf, Delphine Bastelica, Audrey M. Neyrinck, Francesca Fava, Kieran M. Tuohy, Chantal Chabo, Aurélie Waget, Evelyne Delmée, Béatrice Cousin, Thierry Sulpice, Bernard Chamontin, Jean Ferrières, Jean-François Tanti, Glenn R. Gibson, Louis Casteilla, Nathalie M. Delzenne, Marie Christine Alessi and Rémy Burcelin

J Clin Invest. 1996 Jun 15;97(12):2859-65. Mechanism of free fatty acid-induced insulin resistance in humans. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI.

Pak J Biol Sci. 2010 Aug 1;13(15):723-30. Review. Lipid peroxidation alterations in type 2 diabetic patients. Marjani A.

Hypertension. 2004 Feb;43(2):358-63. Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion. Goodfriend TL, Ball DL, Egan BM, Campbell WB, Nithipatikom K.

Malondialdehyde (MDA) level in diabetic subjects. Relationship with blood glucose and glycosylated hemoglobin. Noberasco G, Odetti P, Boeri D, Maiello M, Adezati L.

Singapore Med J. 2008 Feb;49(2):129-36. Blood lipid peroxidation (superoxide dismutase, malondialdehyde, glutathione) levels in Egyptian type 2 diabetic patients. Soliman GZ.

Andrologia. 2012 May;44 Suppl 1:565-70. High levels of lipid peroxidation in semen of diabetic patients. La Vignera S, Condorelli RA, Vicari E, D’Agata R, Salemi M, Calogero AE.

J Enzyme Inhib Med Chem. 2013 Aug;28(4):690-4. Famotidine inhibits glycogen synthase kinase-3β: an investigation by docking simulation and experimental validation. Mohammad M, Al-Masri IM, Issa A, Al-Ghussein MA, Fararjeh M, Alkhatib H, Taha MO, Bustanji Y.

Endocrinology. 2012 May;153(5):2099-111. The lipid peroxidation by-product 4-hydroxy-2-nonenal (4-HNE) induces insulin resistance in skeletal muscle through both carbonyl and oxidative stress. Pillon NJ, Croze ML, Vella RE, Soulère L, Lagarde M, Soulage CO.

J Nutr Biochem. 2014 Jan;25(1):66-72. Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes. Yang SJ, Choi JM, Kim L, Park SE, Rhee EJ, Lee WY, Oh KW, Park SW, Park CY.

N Am J Med Sci. 2013 Sep;5(9):562-6. Blood Viscosity, Lipid Profile, and Lipid Peroxidation in Type-1 Diabetic Patients with Good and Poor Glycemic Control. Mishra N, Singh N.

Curr Opin Lipidol. 2011 Jun;22(3):186-91. Role of peripheral serotonin in glucose and lipid metabolism. Watanabe H, Rose MT, Aso H.

Diabetes Metab. 2005 Feb;31(1):63-8. Increased plasma concentration of nitric oxide in type 2 diabetes but not in nondiabetic individuals with insulin resistance. Chien WY, Yang KD, Eng HL, Hu YH, Lee PY, Wang ST, Wang PW.

PLoS One. 2016 Aug 30;11(8):e0161548. Role of Pro-Inflammatory Cytokines and Biochemical Markers in the Pathogenesis of Type 1 Diabetes: Correlation with Age and Glycemic Condition in Diabetic Human Subjects. Fatima N, Faisal SM, Zubair S, Ajmal M, Siddiqui SS, Moin S, Owais M.

PLoS One. 2014 Feb 4;9(2):e88058. Effect of Peripheral 5-HT on Glucose and Lipid Metabolism in Wether Sheep. Watanabe H, Saito R, Nakano T, Takahashi H, Takahashi Y, Sumiyoshi K, Sato K, Chen X, Okada N, Iwasaki S, Harjanti DW, Sekiguchi N, Sano H, Kitazawa H, Rose MT, Ohwada S, Watanabe K, Aso H.

Diabetes Metab J. 2016 Apr;40(2):89-98. Serotonin as a New Therapeutic Target for Diabetes Mellitus and Obesity. Oh CM, Park S, Kim H.

J Clin Endocrinol Metab. 2005 Feb;90(2):1100-5. Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects. Kashyap SR, Roman LJ, Lamont J, Masters BS, Bajaj M, Suraamornkul S, Belfort R, Berria R, Kellogg DL Jr, Liu Y, DeFronzo RA.

World J Diabetes. 2015 Apr 15;6(3):456-80. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. Tangvarasittichai S.

J Diabetes Complications. 2016 Nov – Dec;30(8):1593-1599. Diabetes and increased lipid peroxidation are associated with systemic inflammation even in well-controlled patients. de Souza Bastos A, Graves DT, de Melo Loureiro AP, Júnior CR, Corbi SCT, Frizzera F, Scarel-Caminaga RM, Câmara NO, Andriankaja OM, Hiyane MI, Orrico SRP.

Psychoneuroendocrinology. 2016 Sep;71:102-9. Executive Functioning and Diabetes: The Role of Anxious Arousal and Inflammation. Murdock KW, LeRoy AS, Lacourt TE, Duke DC, Heijnen CJ, Fagundes CP.

PLoS One. 2015 Apr 20;10(4):e0125270. Hyperglycaemia Enhances Nitric Oxide Production in Diabetes: A Study from South Indian Patients. Adela R, Nethi SK, Bagul PK, Barui AK, Mattapally S, Kuncha M, Patra CR, Reddy PN, Banerjee SK.

Neuro Endocrinol Lett. 1999;20(5):315-322. Distribution of serotonin and its effect on insulin and glucagon secretion in normal and diabetic pancreatic tissues in rat. Adeghate E, Ponery AS, Pallot D, Parvez SH, Singh J.

J Res Med Sci. 2013 Feb;18(2):89-93. An association of hyperglycemia with plasma malondialdehyde and atherogenic lipid risk factors in newly diagnosed Type 2 diabetic patients. Manohar SM, Vaikasuvu SR, Deepthi K, Sachan A, Narasimha SR.

Diabetes Care. 2002 Mar;25(3):500-4. The effect of estrogen use on levels of glucose and insulin and the risk of type 2 diabetes in american Indian postmenopausal women : the strong heart study. Zhang Y, Howard BV, Cowan LD, Yeh J, Schaefer CF, Wild RA, Wang W, Lee ET.

Int J Appl Basic Med Res. 2017 Apr-Jun;7(2):88-93. Study of lipid peroxidation, nitric oxide end product, and trace element status in type 2 diabetes mellitus with and without complications. Mishra S, Mishra BB.

J Pharmacol Sci. 2012;119(3):243-50. Serotonin potentiates high-glucose-induced endothelial injury: the role of serotonin and 5-HT(2A) receptors in promoting thrombosis in diabetes. Yamada K, Niki H, Nagai H, Nishikawa M, Nakagawa H.

Cell Mol Biol (Noisy-le-grand). 2017 Feb 22;63(1):49-52. Nitric oxide levels in response to the patients with different stage of diabetes. Ozcelik O, Algul S.

Diabete Metab. 1992 Jul-Aug;18(4):264-71. Increased lipid peroxidation in type 2 poorly controlled diabetic patients. Altomare E, Vendemiale G, Chicco D, Procacci V, Cirelli F.

J Biol Chem. 2011 Oct 7;286(40):34959-75. Liver-specific Inducible Nitric-oxide Synthase Expression Is Sufficient to Cause Hepatic Insulin Resistance and Mild Hyperglycemia in Mice. Shinozaki S, Choi CS, Shimizu N, Yamada M, Kim M, Zhang T, Shiota G, Dong HH, Kim YB, Kaneki M.

JAMA Pediatr. 2017 Dec 1;171(12):1200-1207. Association of Antidepressant Medications With Incident Type 2 Diabetes Among Medicaid-Insured Youths. Burcu M, Zito JM, Safer DJ, Magder LS, dosReis S, Shaya FT, Rosenthal GL.

Int J Diabetes Dev Ctries. 2010 Jan;30(1):49-51. Significantly increased levels of serum malonaldehyde in type 2 diabetics with myocardial infarction. Mahreen R, Mohsin M, Nasreen Z, Siraj M, Ishaq M.

Ann Pediatr Endocrinol Metab. 2017 Sep;22(3):145-152. Effects of growth hormone on glucose metabolism and insulin resistance in human. Kim SH, Park MJ.

Diabetes Care. 2013 Dec;36(12):4071-5. Poor Glycemic Control Is Related to Increased Nitric Oxide Activity Within the Renal Circulation of Patients With Type 2 Diabetes. Schneider MP, Ott C, Schmidt S, Kistner I, Friedrich S, Schmieder RE.

Diabetes Metab. 2005 Feb;31(1):63-8. Increased plasma concentration of nitric oxide in type 2 diabetes but not in nondiabetic individuals with insulin resistance. Chien WY, Yang KD, Eng HL, Hu YH, Lee PY, Wang ST, Wang PW.

Eur J Clin Invest. 1988 Aug;18(4):399-404. Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular disease. Barradas MA, Gill DS, Fonseca VA, Mikhailidis DP, Dandona P.

The Journal of Clinical Endocrinology & Metabolism, Volume 38, Issue 5, 1 May 1974, Pages 836–840, Inhibition of Hypoglycemia-Induced Cortisol Secretion by the Serotonin Antagonist Cyproheptadine. JAMES W. PLONK, CARL H. BIVENS, JEROME M. FELDMAN.


You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

Please "like" us:Already liked? You can close this